Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Prostanoids are a group of bioactive lipids working as local mediators and include D, E, F and I types of prostaglandins (PGs) and thromboxanes. Prostacyclin (PGI2) acts on platelets and blood vessels to inhibit platelet aggregation and to cause vasodilatation, and is thought to be important for vascular homeostasis. Aspirin-like drugs, including indomethacin, which inhibit prostanoid biosynthesis, suppress fever, inflammatory swelling and pain, and interfere with female reproduction, suggesting that prostanoids are involved in these processes, although it is not clear which prostanoid is the endogenous mediator of a particular process. Prostanoids act on seven-transmembrane-domain receptors which are selective for each type. Here we disrupt the gene for the prostacyclin receptor in mice by using homologous recombination. The receptor-deficient mice are viable, reproductive and normotensive. However, their susceptibility to thrombosis is increased, and their inflammatory and pain responses are reduced to the levels observed in indomethacin-treated wild-type mice. Our results establish that prostacyclin is an antithrombotic agent in vivo and provide evidence for its role as a mediator of inflammation and pain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, M. J., & de Beer, E. J. (1959) · Cited by 2,671
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, W. N., & de Beer, E. J. (1959) · Medical Entomology and Zoology · Cited by 2,132
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108 · cited 1×
“The generation of chimaeras and mutant mice has been describe”
BackgroundSelf-citationProstaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082 · cited 1×
“A similar abnormal mendelian ratio of male F 2 progeny was reported for cyclooxygenase-2-deficient mic”
BackgroundMalmberg, A. B., & Yaksh, T. L. (1992) · Science · doi:10.1126/science.1381521 · Cited by 710 · cited 1×
“but also by facilitating pain transmission at the spina”
BackgroundThe Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation
Davies, P. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.335 · Cited by 467
Rat model of arterial thrombosis induced by ferric chloride
Kurz, K. D., Main, B. W., & Sandusky, G. E. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90106-m · Cited by 431 · cited 1×
“5% FeCl 3 solution, a procedure known to injure the endotheliu”
Background
Cited by
Items 601–700 of 783
Pulmonary Embolism in a Woman Taking Oral Contraceptives and Valdecoxib
Westgate, E. J., & FitzGerald, G. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020197 · Cited by 6
“Deletion of the prostacyclin receptor in mice does not cause spontaneous thrombosis, but rather enhances the response to thrombotic stimuli [9].”
BackgroundSilent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease
Deeb, R. S., Lamon, B. D., & Hajjar, D. P. (2009) · Current Hypertension Reviews · doi:10.2174/157340209789587726 · Cited by 6
“Surprisingly, PGI2 receptor-deficient mice displayed no associated renal abnormalities[59].”
BackgroundOpportunities in pain therapy:beyond the opioids and NSAIDs
Kowaluk, E. A., Arnerić, S. P., & Williams, M. J. (1998) · Emerging Drugs · doi:10.1517/14728214.3.1.1 · Cited by 6
Kuroda, T., Hirota, H., Fujio, Y., Sugiyama, S., Masaki, M., Hiramoto, Y., Shioyama, W., Okamoto, K., Hori, M., & Yamauchi‐Takihara, K. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.04.003 · Cited by 6
“While transgenic mice with selective pulmonary over-expression of the prostacyclin synthase gene are protected against the development of hypoxia-induced pulmonary hypertension [17], IP receptor deficient mice exhibit more severe vascular remodeling in response to hypoxia [4], and are more susceptible to thrombosis [1…”
BackgroundBarnwal, B., & Kini, R. M. (2013) · Biochemical Journal · doi:10.1042/bj20130599 · Cited by 6
Khan, B., Bauman, W. A., Sinha, A., & Kahn, N. N. (2011) · Spinal Cord · doi:10.1038/sc.2011.33 · Cited by 6
Smyth, E. M., & FitzGerald, G. A. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50528-3 · Cited by 6
Rang, H. P., Dale, M. M., Ritter, J., & Flower, R. J. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06911-6.50024-4 · Cited by 8
Activation-Dependent Internalization of The Human Prostacyclin Receptor
Smyth, E. M., Austin, S. C., & FitzGerald, G. A. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0_45 · Cited by 5
Reid, H. M., Maginn, M., Perkins, C. M., Mulvaney, E. P., Boyce, M. J., Yamamoto, T., & Kinsella, B. T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1296188 · Cited by 5
Kurumatani, H. (2009) · Folia Pharmacologica Japonica · doi:10.1254/fpj.133.101 · Cited by 6
Kim, A. (2016) · Food Science and Biotechnology · doi:10.1007/s10068-016-0187-3 · Cited by 6
Chen, P., Gao, H., Lu, Y., Nie, H., Liu, Z., Zhao, Y., Fan, N., Zou, Q., Dai, Y., Tang, A., et al. (2017) · Cell Biology International · doi:10.1002/cbin.10782 · Cited by 5
“Mice deficient in its receptor showed susceptibility to thrombosis (Murata et al., 1997).”
BackgroundOhkura, M., Ohkura, N., Yoshiba, N., Yoshiba, K., Ida‐Yonemochi, H., Ohshima, H., Saito, I., & Okiji, T. (2017) · Odontology · doi:10.1007/s10266-017-0309-2 · Cited by 5
Ciclooxigenasa 2: ¿una nueva diana terapéutica en la aterosclerosis?
Páramo, J. A., Beloqui, Ó., & Orbe, J. (2006) · Medicina Clínica · doi:10.1157/13089104 · Cited by 5
Latest discoveries in prostaglandin receptor modulators
Dogné, J., de Leval, X., Pirotte, B., & Benoit, P. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.8.1225 · Cited by 5
“Although the precise physiological roles of each receptor remains only partially characterised, they can be summarised as follows: • IP: the biologicalal effects of prostacyclin are numerous and include nocioception, antithrombosis [3] and vasodilator actions, which have been targeted therapeutically to treat pulmonar…”
BackgroundInhibitory Effect of Chan-Su on the Secretion of PGE2 and NO in LPS-stimulated BV2 Microglial Cells
Kim, M. H., Lyu, J. H., Lyu, S. A., Hong, S. H., Kim, W. I., Yoon, H., & Ko, W. S. (2008) · 동의생리병리학회지 · Cited by 5
Themed section: molecular pharmacology of GPCRs
Summers, R. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01679.x · Cited by 7
Prostaglandins: Key players in immunomodulation of the nervous system
Wang, Z., Sun, Y., Luo, M., He, N., Wen, Z., Wang, Z., Zhang, Y., Zhao, J., & Liu, Y. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00089 · Cited by 6
Chapter 6 The Human Prostacyclin Receptor
Martin, K. A., Gleim, S., Elderon, L., Fetalvero, K. M., & Hwa, J. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)89006-6 · Cited by 5
Jana, B., Całka, J., Andronowska, A., Mówińska, A., Witek, K. J., & Palus, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126313 · Cited by 4
“PGI2 is a very important component in inflammatory reactions [11,12] and affects the contractility of the inflamed pig uterus [10].”
BackgroundChapter 64 Antithrombotic agents for stroke prevention
Schwartz, N. E., Diener, H., & Albers, G. W. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)94064-1 · Cited by 4
Hypothetical mechanism of prostaglandin E1-induced bronchoconstriction
Uchida, K., Tateda, T., & Takagi, S. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00174-9 · Cited by 4
Daniel, V. (2014) · Springer eBooks · doi:10.1007/978-3-642-27728-3_42-1 · Cited by 4
Gao, Y. (2022) · Springer eBooks · doi:10.1007/978-981-19-7122-8_8 · Cited by 4
Pharmacotherapy of acute orofacial pain
Sharav, Y., & Benoliel, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7234-3412-2.10015-x · Cited by 8
Terashima, S., Nishio, H., Ogura, M., Honda, M., & Takeuchi, K. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.11.014 · Cited by 4
Not a mouse stirring: deletion of the EP2 and love’s labor’s lost
Austin, S. C., & FitzGerald, G. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7289 · Cited by 4
“However, in both cases, baseline blood pressure is normal (7, 13).”
BackgroundJungner, M., Bentzer, P., & Grände, P. (2009) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181a5f211 · Cited by 4
Lipid Mediators in Inflammation
Narumiya, S., Yokomizo, T., & Aoki, J. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch26 · Cited by 4
Self-citation[Doping: health risks and relation to addictive behaviors].
Siri, F., & Roques, B. P. (2003) · Annales De Medecine Interne · Cited by 4
Update on Arachidonic Acid Cascade
Haeggström, J. Z., & Serhan, C. N. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-253-1_3 · Cited by 5
Kittimongkolsuk, P., Sukjamnong, S., Janpaijit, S., Rangsinth, P., Chumpolphant, S., Chaikhong, K., Leung, G., Hu, V. W., Sarachana, T., Prasansuklab, A., et al. (2025) · Food Frontiers · doi:10.1002/fft2.70052 · Cited by 4
Prostanoid receptors (version 2020.4) in the IUPHAR/BPS Guide to Pharmacology Database
BREYER, R. M., Clapp, L. H., Coleman, R. A., Giembycz, M. A., Heinemann, Á., Hills, R., Jones, R. L., Narumiya, S., Norel, X., Pettipher, R., et al. (2020) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f58/2020.4 · Cited by 3
Self-citationGPCRs in thromboinflammation and hemostasis
Li, J., Xu, H., Knauss, E. A., Woulfe, D. S., & Nieman, M. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00019-2 · Cited by 3
Saito, Y., Yamada, T., Kobayashi, M., Sakakibara‐Konishi, J., Shinagawa, N., Kinoshita, I., Dosaka‐Akita, H., & Iseki, K. (2019) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.19-00148 · Cited by 3
Prostanoid receptors in GtoPdb v.2023.1
Clapp, L. H., Giembycz, M. A., Heinemann, Á., Jones, R. L., Narumiya, S., Norel, X., Sugimoto, Y., Woodward, D. F., & Yao, C. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f58/2023.1 · Cited by 3
Self-citationPatrono, C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00053-5 · Cited by 3
Andreasson, K. I., & Montine, T. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_6 · Cited by 3
Acciones de los prostanoides en la fisiopatología cardiovascular
Díaz‐Muñoz, M. D., Cuesta, N., Cacheiro‐Llaguno, C., & Iñiguez, M. A. (2008) · Anales de la Real Academia Nacional de Farmacia · Cited by 3
Transgenic Animals in Primary Hemostasis and Thrombosis
Gachet, C., Hechler, B., Léon, C., Cazenave, J., & Lanza, F. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18934-0_17 · Cited by 3
“IP-deficient mice are viable, reproductive, and normotensive and have a normal bleeding time, but they display increased sensitivity in a model of FeCl3-induced carotid artery thrombosis (Murata et al. 1997).”
BackgroundDaniel, V. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_42 · Cited by 3
Bridging Chemical and Biological Space: QSAR Probing Using 3D Molecular Descriptors
(2012) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805379711201010119 · Cited by 4
Sugita, R., Kubota, K., Sugimoto, K., Tachida, Y., Shibayama, T., Kiho, T., Kawakami, K., & Shimada, K. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.01.009 · Cited by 3
Anagnostopoulos, A. V., & Scharpf, R. B. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01395-x · Cited by 3
Kinins : important regulators in inflammation induced bone resorption
Brechter, A. B. (2006) · Cited by 3
Kuraishi, Y., & Ushikubi, F. (2001) · Folia Pharmacologica Japonica · doi:10.1254/fpj.117.248 · Cited by 3
Self-citationAl-Abbasi, Z., Bhuiyan, S. A., Renthal, W. R., & Molliver, D. C. (2025) · SSRN Electronic Journal · doi:10.1101/2025.04.03.643725 · Cited by 3
Inhibition of TRPM8 function by prostacyclin receptor agonists requires coupling to Gq/11 proteins
Trif, C., Banica, A., Manolache, A., Anghel, S. A., Huţanu, D., Stratulat, T., Badea, R. A., Oprita, G., Şelescu, T., Petrescu, S. M., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16295 · Cited by 2
“Studies performed on mice genetically modified to lack the Ptgir gene that encodes the IP receptor also demonstrated its involvement in pain and inflammation, as inflammatory and pain responses were significantly reduced in IP receptor-deficient mice (Murata et al., 1997).”
Background(2016) · Wiley eBooks · doi:10.1002/9783527685059.ch2 · Cited by 2
Michelson, A. P., Lyons, P. G., Nguyen, N. M., Reynolds, D., McDonald, R., McEvoy, C. A., Despotovic, V., Brody, S. L., Kollef, M. H., & Kraft, B. D. (2023) · CHEST Critical Care · doi:10.1016/j.chstcc.2023.100019 · Cited by 2
Prasongtanakij, S., Soontrapa, K., & Thumkeo, D. (2025) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2025.151482 · Cited by 2
Harney, D. F., Dooley, M., Harhen, B., McGuiness, N., Cagney, G., McCrory, C. R., Fitzgerald, D. J., & Dowd, N. P. (2008) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000289528.87796.0b · Cited by 2
“Prostaglandins, mostly PGE2 and prostacyclin, are important mediators of inflammation and pain.(1,2)”
BackgroundCytokines (Tumor Necrosis Factor, Interleukins) and Prostaglandins
Alstergren, P. J. (2009) · Wiley eBooks · doi:10.1002/9780470522226.ch17 · Cited by 3
Zhang, T.-Q., Kuroda, H., Nagano, K., Terada, S., Gao, J., Harada, K., Hirata, K., Tsujino, H., Higashisaka, K., Matsumoto, H., et al. (2019) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2019.102032 · Cited by 2
Nutraceutical Alternatives to Pharmaceutical Analgesics in Osteoarthritis
Heffernan, S. M., & Conway, G. E. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95919 · Cited by 2
“periphery and enhance the activity of various pain mediators [104, 107].”
BackgroundProstaglandins and Other Lipid Mediators in Reproductive Medicine
Funk, C. D., Song, W., & FitzGerald, G. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00006-8 · Cited by 2
The choreography of cyclooxygenases in the kidney
FitzGerald, G. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216044 · Cited by 2
Lee, D. H., & Blajchman, M. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50795-3 · Cited by 2
Efeito da sinvastatina na lesão muscular induzida por estiramento passivo em ratos.
Tomazoni, S. S. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2012.tde-26072012-164748 · Cited by 3
Interpretation of Thrombosis Prevention Trial
FitzGerald, G. A., & Charman, W. N. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79155-8 · Cited by 2
New insights into inflammatory resolution
Gilroy, D. W., Lawrence, T., Colville‐Nash, P., & Willoughby, D. A. (2001) · Inflammopharmacology · doi:10.1163/156856001300248399 · Cited by 2
“In a carrageenin-induced pleurisy and paw swelling model, it was shown recently that the degree of in ammation in prostacyclin receptorde cient mice was reduced and was comparable to the reduction typically seen when normal animals were dosed with indomethacin (Murata et al., 1997).”
ResultInflammation, Immunology and Allergy
Steinhoff, M. S. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0008 · Cited by 3
Smyth, E. M., & FitzGerald, G. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00150-9 · Cited by 3
Prostacyclin as a Negative Regulator of Angiogenesis in the NeurovasculaturePreprint
Womack, T., Li, J., Govyadinov, P. A., Mayerich, D. M., & Eriksen, J. L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.28.441854 · Cited by 2
“Early reports found that intradermal injections in mice with exogenous prostacyclin combined with nitric oxide donors or bradykinin synergistically increased vascular permeability, but not when administered alone [23, 24].”
BackgroundPlatelets and coagulation: partners in haemostasis
Swieringa, F. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160331fs · Cited by 2
Prostanoids regulate vascular permeability
Horikami, D., Kobayashi, K., & Murata, T. (2020) · Folia Pharmacologica Japonica · doi:10.1254/fpj.20045 · Cited by 1
Self-citationBlood Constituents and Safety Pharmacology: In Vitro and In Vivo Thrombosis and Hemostasis Assays
Mousa, S. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_75 · Cited by 1
Pires, M. E. L., Shala, F., Soffientini, U., Cypaite, N., Vinokurova, M., Gashaw, H. H., Vaja, R., Ferreira, P., Elghazouli, Y., Vadgama, A., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202501900r · Cited by 1
“This model was chosen as a historically established gold standard for measuring thrombosis in vivo, and because we (and others) have shown it is sensitive to the pro-thrombotic effects of NSAIDs, endothelial cyclo- oxygenase-2 deletion [6], and prostacyclin deficiency [6, 31].”
Safety Pharmacology of Antiinflammatory Drugs
Vogel, H. G. (2006) · Springer eBooks · doi:10.1007/3-540-29804-5_11 · Cited by 1
Eicosanoids and Renal Function
Breyer, M. D., Harris, R. C., & BREYER, R. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00017-3 · Cited by 1
NSAID Action and the Foundations for Cardiovascular Toxicity
Blobaum, A. L., & Marnett, L. J. (2010) · Wiley eBooks · doi:10.1002/9780470660379.ch8 · Cited by 1
Activity on blood constituents
Vogel, H. G., & Vogel, W. H. (1997) · Springer eBooks · doi:10.1007/978-3-662-03333-3_2 · Cited by 1
Shilpi, J. A. (2006) · Oriental Pharmacy and Experimental Medicine · doi:10.3742/opem.2006.6.1.021 · Cited by 1
Preliminary pharmacological evaluation of an Ayurvedic formulation Dasamularista
Sultana, R., Kabir, C. M. S., Mafruhi, S., & Masum, S. (2006) · Oriental Pharmacy and Experimental Medicine · doi:10.3742/opem.2006.6.3.208 · Cited by 2
Platelet Prostanoids and their receptors
Fries, S., & Großer, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_15 · Cited by 1
Activity on blood constituents1
Vogel, H. G., Vogel, W. H., Schölkens, B. A., Sandow, J., Müller, G. A., & Vogel, W. F. (2002) · Springer eBooks · doi:10.1007/3-540-29837-1_3 · Cited by 1
Steinhoff, M. S., Groves, R. W., LeBoit, P. E., & Luger, T. A. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch12 · Cited by 2
Inhibition of Platelet Function by the Endothelium
Koupenova, M., & Freedman, J. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00017-5 · Cited by 1
Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3471-8.00022-6 · Cited by 4
Watanabe, H., Song, T., Choi, J., Lee, M., Choi, K., Kim, J., Sherry, B. A., Diamond, B., Zou, Y.-R., & Son, M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1588987 · Cited by 1
Blood Constituents and Safety Pharmacology
Mousa, S. A. (2013) · Springer eBooks · doi:10.1007/978-3-642-25240-2_12 · Cited by 1
Synthesis and Pharmacological Properties of Fluorinated Prostanoids
Matsumura, Y. (2008) · Elsevier eBooks · doi:10.1016/b978-0-444-53086-8.00014-x · Cited by 1
Agents Acting on Prostanoid and Thromboxane Receptors
Hall, A., Peace, S., & Swarbrick, M. E. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc064.pub2 · Cited by 1
The roles of the prostanoids played in the body.
Ushikubi, F., & Narumiya, S. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.201 · Cited by 1
Self-citationNarumiya, S. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18934-0_15 · Cited by 1
“A study on IP / mice (Murata et al. 1997) indeed showed that, while they develop and age normally, they show an enhanced thrombotic tendency when endothelial damage is evoked.”
BackgroundMethodInfluentialSelf-citationA comparison of the pharmacological modulation of hyperalgesia and bronchial hyperresponsiveness
Spina, D. (2003) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/s1094-5539(02)00173-6 · Cited by 1
Prostaglandins in the patent literature
Ebenezar, K. K., & Smith, F. G. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.9.1131 · Cited by 1
“Biological effects of PGI 2 are numerous and include nocioception, antithrombosis [23] and vasodilator actions, which have been targeted therapeutically to treat pulmonary hypertension [24] .”
BackgroundAgents Acting on Prostanoid Receptors
Jenkins, D. W., Humphrey, P. P. A., & Coleman, R. A. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc064 · Cited by 1
Morita, I. (1999) · Ensho · doi:10.2492/jsir1981.19.69 · Cited by 1
Isolation, cloning and characterisation of IP-receptors
(2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46822-0_4 · Cited by 1
Gresele, P., & Vezza, R. (2000) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8476-1_3 · Cited by 1
Smyth, E. M., & FitzGerald, G. A. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm0870 · Cited by 1
Lipid Mediators and Tissue Factor Expression
Takeya, H., & Suzuki, K. (2009) · Springer eBooks · doi:10.1007/978-4-431-78847-8_7 · Cited by 1
Prostacyclin and Lung Cancer Chemoprevention
Keith, R. L., Miller, Y. E., Bunn, P. A., Nana-Sinkam, P. S., Nemenoff, R. A., & Geraci, M. W. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-767-3_11
Pharmacological Assays in Thrombosis and Haemostasis
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_3
Safety Pharmacology of Blood Constituents
Mousa, S. A. (2006) · Springer eBooks · doi:10.1007/3-540-29804-5_13
The Role of Prostaglandin E2/EP4 Prostanoid Receptor Signaling in Colorectal Carcinogenesis
Chandramouli, A. (2009) · UA Campus Repository (The University of Arizona)
Prostanoid Generation in Platelet Function
Rocca, B., & Patrono, C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-917-2_11
On the role of the inducible enzymes iNOS and COX-2 in colitis
Kankuri, E. M. (2002) · Työväentutkimus Vuosikirja
Metadata
- Authors
- Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S., & Narumiya, S.
- Affiliations
- Kyoto University (JP)
- Ono Pharmaceutical (Japan) (JP)
- Osaka Women's and Children's Hospital (JP)
- Kitasato University (JP)
- Corresponding author
- Narumiya, Shuh
- Venue
- Nature
- Published
- 1997-08-14
- Volume
- 388
- Issue
- 6643
- Pages
- 678-682
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1666619344
- Cited by
- 773
- References
- 27
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 14 · 2020: 15 · 2019: 21 · 2018: 14 · 2017: 23 · 2016: 18 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 33
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- prostacyclin receptor, prostacyclin, prostanoids, pain perception, inflammation, thrombosis, indomethacin, prostaglandins, thromboxane, knockout mice, antithrombotic agents, vascular homeostasis
- MeSH terms
- Animals, Antithrombins, Blood Pressure, Inflammation, Mice, Inbred C57BL, Pain, Platelet Aggregation, Epoprostenol, Receptors, Prostaglandin, Thrombosis, Restriction Mapping, Dinoprostone, Mutagenesis, Gene Targeting, Receptors, Epoprostenol, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.